MLR-1023 Treatment in Mice and Humans Induces a Thermogenic Program, and Menthol Potentiates the Effect

A glucose-lowering medication that acts by a different mechanism than metformin, or other approved diabetes medications, can supplement monotherapies when patients fail to meet blood glucose goals. We examined the actions underlying the effects of an insulin sensitizer, tolimidone (MLR-1023) and inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebello, Candida J., Coulter, Ann A., Reaume, Andrew G., Cong, Weina, Cusimano, Luke A., Greenway, Frank L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625945/
https://www.ncbi.nlm.nih.gov/pubmed/34832978
http://dx.doi.org/10.3390/ph14111196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625945/
https://www.ncbi.nlm.nih.gov/pubmed/34832978
http://dx.doi.org/10.3390/ph14111196

Ejemplares similares